well posit meet/beat expect report monday howev
expect continu set conserv initi fy guidanc like core growth
combin investor uncertainti regard china chemical/energi may
overhang expect otherwis strong updat view valuat
multi-quart outlook compel buy weak
manag guid core revenu growth y/i model core growth
y/i note week ago time origin agil quarterli
preview link tool quarterli believ agil well posit post
least core growth see path higher like consist buy-
side expect model fx headwind revenu growth consist
guidanc recent fx weak applic see
convict upsid simpl guidanc impli core revenu growth deceler
vs despit easier y/i comparison across mani import revenu
line particularli pharma could improv china food environ
agil peer result date demonstr robust end market growth
environ roch tissu dx particular note among peer result china
grew grew
current model ep line consensu high end guidanc
expect agil ultim reach exceed forecast though see less room
ep upsid usual unless agil abl notabl exceed core revenu growth
primari headwind tariff impact incorpor guidanc
exclud tariff cost underli forecast impli increment oper
one concern strong print larger cap tool stock react well
day quarterli updat see chart includ herein said note
appreci sinc strong updat appreci sinc updat weak
major buy-back announc good updat flat sinc sell
day compani report recogn agil under-perform
group year expect good updat agil could pull eps-
upsid drive lever see think risk/reward okay mayb
morn
expect core revenu growth guidanc approxim ep
approxim sinc manag consist provid initi core revenu
growth guidanc subsequ grown howev
increment revenu new nasd facil expect slightli higher
start point make sens reduc core revenu growth forecast
though continu believ agil ultim put anoth year
growth compani past year
continu page
pleas see page report import disclosur
continu view agil posit competit perspect continu
believ compani potenti gener signific margin expans next
sever year confid manag margin target believ could
room upsid view guidanc rel conserv clear
potenti driver upsid seemingli littl downsid risk top bottom
line either buyer seller could drive upsid also provid downsid
protect like near- long-term outlook recent pullback also like
valuat rate share outperform price target base dcf analysi
repres ev/ebitda
multipl group
agil acquir larger
organ growth oper margin
exceed
growth expect
possibl addit
lack growth render multipl high
growth lower expect
expect margin expans fail
life scienc diagnost chemic analysi compani
compani current oper segment life scienc appli market lsag
diagnost genom dgg agil crosslab group acg
also expect fx repres materi headwind previous expect due
recent broad usd strengthen model headwind revenu
growth vs prior expect headwind accordingli reduc ep
forecast
worth note potenti lever agil could pull drive ep upsid
outsid core result includ implement use lower non-gaap tax rate
current cash tax rate low teen and/or aggress balanc sheet deploy
multipl overhang believ could weigh stock perform
next month includ conserv guidanc china macro fear
above-group averag exposur agil sale china chemical/
 extrem difficult core revenu growth comparison
also worth note tool stock perform well earn
except true blow-out number
agil trade roughli line peer price-to-earnings basi discount ev/
ebitda basi discount p/fcf basi despit outlook above-
peer averag top- bottom-lin growth well one best balanc sheet
group like stock would readi buy weak come month
due overhang note aggress buyer less look beyond
next month setup improv materi revenu growth acceler
investor begin look toward agil could
grow aid new nasd facil maintain outperform rate
compani report thomson eikon cowen compani
tickerbrkrdhrmtdpkitmowatreport date pmoct pmoct pmoct amoct enu actual enu consensu ep actual ep consensu consensu pre-report consensu post-report enu guidanceorgan growth local currenc organ organ cc consensu pre-report consensu post-report ep consensu pre-report ep consensu post-report ep guidanc ep consensu pre-report ep consensu post-report perform day perform report date cowen
compani report thomson eikon cowen compani
cowen vs consensu mm except core fx core fx report adjust segment metric mm except growth growth growth statement mm except growth currenc maintain forecast y/i sale due lasergen invest maintain sg forecast margin per count increas gross margin forecast repres q/q expans agil expect headwind due tariff reflect gross margin forecast said believ possibl agil abl off-set via price increas initi see potenti upsid rel forecast past year gross margin increas q/q seem like occur despit tariff headwind increas ep forecast line high end guidanc consensu expect assum core revenu growth increment oper margin room ep upsid maintain lsag revenu forecast repres y/i core growth ultim see clear room upsid forecast forecast assum deceler rel core growth despit favor y/i comparison vs still favor two year stack comparison end market comparison also favor along strong end market backdrop across pharma larg molecul small molecul via acg icp-m chemical/energi china food headwind appear bake expect maintain acg revenu forecast repres y/i core growth ultim acg track grow high-singl digit consecut year reason momentum slow continu strong end market geograph backdrop acg grew mid-teen china expect acg meet exceed forecast mark favor two year stack comparison year acg still maintain dgg revenu forecast repres core growth y/i dgg grown past two quarter though exclud two isol headwind pain manag tough nasd comparison underli growth remain return nasd growth expect quarter along continu solid genom patholog growth believ dgg abl least reach forecast increas adjust oper margin forecast howev believ clear room upsid agil abl post revenu upsid expect forecast assum increment oper margin still includ y/i headwind increas lasergen invest still seem reason agil abl post core revenu growth revenu upsid oper margin maintain core revenu growth forecast y/i model revenu larg line consensu ultim believ agil post organ revenu growth y/i upsid rel forecast driven primarili lsag lesser extent acg confid upsid driven bottom model analysi comparison across segment end market etc continu solid end market backdrop robust growth across agil two major end market pharma chemical/energi geographi china us expect bake china food ministri reorgan headwind cowen
compani report thomson eikon cowen compani
mm except per share datajan net net core fx acq core fx currenc contribut adjust segmentlif scienc appli group currenc contribut adjust crosslab group currenc contribut adjust genom group currenc contribut adjust currenc currenc pacif growth china currenc end marketpharma growth growth growth growth growth total food biz chinareport growth cowen
compani report thomson eikon cowen compani
mm except per share datajan core fx core fx aconst gener oper oper report adjust non-oper incl keysight bill net interest net interest expens tax rate re-affirmed net earn per expectationsjan gross op cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
risk downsid includ limit macroeconom deterior
current level challeng china disrupt due keysight spin eros market
share price due competit inabl deliv incremental/decrement margin
target value-destruct
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock thermo fisher scientif secur
cowen compani llc manag co-manag public offer past month
cowen compani llc receiv compens invest bank servic past month
past month client cowen compani llc cowen compani llc provid provid invest bank servic
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
